Zhenjian Zhuo and Jing He*
Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, People’s Republic of China
*Corresponding Author: Jing He, Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, People’s Republic of China.
Received: May 26, 2020; Published: July 17, 2020
More than 80% of the human genome is actively transcribed but only about 2%-3% is translated into proteins, indicating that the transcriptional output of human genome is almost monopolized by non-coding RNAs (ncRNAs) [1]. Cancer relevant ncRNAs are gradually becoming one of the hottest issues in the RNA biology and oncology [2]. Reports on ncRNAs are colorful and diversified. Many researchers have engrossed in the subject about ncRNAs including long noncoding RNAs (lncRNAs), microRNAs, and piRNAs, exploring their biological mechanisms and regulatory pathways in some complex diseases.
Citation: Zhenjian Zhuo and Jing He. “Newly lncRNAs SNPs been Identified, What Exact Role will it Act in Cancer?” Acta Scientific Cancer Biology 4.8 (2020): 12-13.
Copyright: © 2020 Zhenjian Zhuo and Jing He. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
